Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Howell

Showing results (431-440 of 743) with videos related to

Pageof 75
Sort By:
Journal of Carcinogenesis|January 27, 2012
MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: Insights for chemopreventionLaura A Kresty, Jennifer Clarke, Kristin Ezell, et al.
The Lancet. Neurology|November 25, 2015
The genetic landscape of the epileptic encephalopathies of infancy and childhoodAmy McTague, Katherine B Howell, J Helen Cross, et al.
Molecular Pharmacology|June 4, 2010
The role of the methionines and histidines in the transmembrane domain of mammalian copper transporter 1 in the cellular accumulation of cisplatinChristopher A Larson, Preston L Adams, Brian G Blair, et al.
The Journal of Clinical Psychiatry|March 28, 2008
Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetineKimberly A Yonkers, Haiqun Lin, Heather B Howell, et al.
Seminars in Oncology|February 1, 1991
Intraperitoneal cisplatin-based chemotherapy for ovarian carcinomaS B Howell, S Kirmani, E F McClay, et al.
Cancer Research|May 15, 1994
Cellular pharmacology of dichloro(ethylenediamine)platinum(II) in cisplatin-sensitive and resistant human ovarian carcinoma cellsA P Jekunen, D K Hom, J E Alcaraz, et al.
Journal of the National Cancer Institute|October 23, 1997
Loss of DNA mismatch repair: effects on the rate of mutation to drug resistanceM M de las Alas, S Aebi, D Fink, et al.
Oncology Reports|September 2, 2014
Reactive oxygen species promote ovarian cancer progression via the HIF-1α/LOX/E-cadherin pathwayYu Wang, Jun Ma, Haoran Shen, et al.
Oncotarget|September 18, 2015
Cranberry proanthocyanidins inhibit esophageal adenocarcinoma in vitro and in vivo through pleiotropic cell death induction and PI3K/AKT/mTOR inactivationLaura A Kresty, Katherine M Weh, Bree Zeyzus-Johns, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 4, 2019
Securing the Payload, Finding the Cell, and Avoiding the Endosome: Peptide-Targeted, Fusogenic Porous Silicon Nanoparticles for Delivery of siRNAByungji Kim, Si Sun, Judith A Varner, et al.
Pageof 75

Showing results (431-440 of 743) with videos related to

Sort By:
Pageof 75
Journal of Carcinogenesis|January 27, 2012
MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: Insights for chemopreventionLaura A Kresty, Jennifer Clarke, Kristin Ezell, et al.
The Lancet. Neurology|November 25, 2015
The genetic landscape of the epileptic encephalopathies of infancy and childhoodAmy McTague, Katherine B Howell, J Helen Cross, et al.
Molecular Pharmacology|June 4, 2010
The role of the methionines and histidines in the transmembrane domain of mammalian copper transporter 1 in the cellular accumulation of cisplatinChristopher A Larson, Preston L Adams, Brian G Blair, et al.
The Journal of Clinical Psychiatry|March 28, 2008
Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetineKimberly A Yonkers, Haiqun Lin, Heather B Howell, et al.
Seminars in Oncology|February 1, 1991
Intraperitoneal cisplatin-based chemotherapy for ovarian carcinomaS B Howell, S Kirmani, E F McClay, et al.
Cancer Research|May 15, 1994
Cellular pharmacology of dichloro(ethylenediamine)platinum(II) in cisplatin-sensitive and resistant human ovarian carcinoma cellsA P Jekunen, D K Hom, J E Alcaraz, et al.
Journal of the National Cancer Institute|October 23, 1997
Loss of DNA mismatch repair: effects on the rate of mutation to drug resistanceM M de las Alas, S Aebi, D Fink, et al.
Oncology Reports|September 2, 2014
Reactive oxygen species promote ovarian cancer progression via the HIF-1α/LOX/E-cadherin pathwayYu Wang, Jun Ma, Haoran Shen, et al.
Oncotarget|September 18, 2015
Cranberry proanthocyanidins inhibit esophageal adenocarcinoma in vitro and in vivo through pleiotropic cell death induction and PI3K/AKT/mTOR inactivationLaura A Kresty, Katherine M Weh, Bree Zeyzus-Johns, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 4, 2019
Securing the Payload, Finding the Cell, and Avoiding the Endosome: Peptide-Targeted, Fusogenic Porous Silicon Nanoparticles for Delivery of siRNAByungji Kim, Si Sun, Judith A Varner, et al.
Pageof 75